Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by IWillRetireSoonon Feb 06, 2016 9:51am
191 Views
Post# 24531563

RE:RE:Very important phrases from Euro-Pacific report...

RE:RE:Very important phrases from Euro-Pacific report...Just as I said, it ain't over. Yet I would NOT be hung up on the word "small". That term is meaningless since FDA defined Telesta's sample of under 150 to be insufficient. What is "small"? I want to see managements strategy. FDA has stated that they will provide guidance for another trial. That is to be the determiner of the test size. If management can get a clear picture of what would FDA consider an acceptable trial size then then all that is to be determined is time frame and costs of trial..... that would be compared to cash on hand and cash flow. This is what I want to hear about from management. Again, it ain't over yet. NowRetired.
<< Previous
Bullboard Posts
Next >>